[Retracted] miR­663 promotes NPC cell proliferation by directly targeting CDKN2A.

Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that certain of the cell cycle assay data shown in Figs. 2D and 5C were strikingly similar to data appearing in different form in other articles by different authors. Owing to the fact that the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to Molecular Medicine Reports, the Editor has decided that this paper should be retracted from the Journal. After having been in contact with the authors, they agreed with the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused. [the original article was published in Molecular Medicine Reports 16: 4863­4870, 2017; DOI: 10.3892/mmr.2017.7129].

miR-663b promotes tumor cell proliferation, migration and invasion in nasopharyngeal carcinoma through targeting TUSC2.

[This retracts the article DOI: 10.3892/etm.2017.4608.].

[Effect of intensity modulated radiation therapy on oral mucosa and immune function in patients with nasopharyngeal carcinoma].

OBJECTIVE: To study the potential effects of intensity modulated radiation therapy (IMRT) on clinical efficacy, oral mucosa reaction and immunological foundation; and to explore the effect of immunological changes on clinical efficacy and oral mucosa reaction in patients with nasopharyngeal carcinoma.
 Methods: A total of 200 patients with nasopharyngeal carcinoma, who came from First Department of Nasopharyngeal Radiotherapy, the First People's Hospital of Foshan from October 2008 to November 2011, were selected. The patients were treated with nasopharyngeal radiotherapy, and divided into an observation group and a control group (n=100 in each group). The control group underwent common conventional two-dimensional radiotherapy treatment, while the observation group underwent IMRT. The 5-year survival rates and recurrence rates were recorded at follow-up. After the radiotherapy, the oral mucosa in the patients were evaluated by the classification standard of acute radioactive mucositis by American Radiotherapy Oncology Group (RTOG), and the number of T lymphocyte subsets before and after treatment was detected.
 Results: There were significant difference in non-regional-recurrence survival rate, disease-free survival rate, local recurrence rate between the above 2 groups (all P<0.05), but no significant difference in the distant metastasis-free survival rate (P>0.05). The acute oral mucosa reactions of grade 1, 2, 3, 4 in the control group were 8.00%, 20.00%, 12.00%, 7.00%, respectively, and those were 7.00%, 22.00%, 15.00%, 1.00% respectively. There was no significant difference in the acute response of oral mucosa in grade 1, 2 and 3 in the 2 groups (all P>0.05), but there was significant difference in the grade 4 (P<0.05). There were significantly difference in CD8+, CD4+/ CD8+ and CD4+ T lymphocyte subsets before and after treatment in the above 2 groups (all P<0.01); there were also significantly difference after treatment between the observation group and the control group (all P<0.01).
 Conclusion: In the process of treatment in patients with nasopharyngeal carcinoma, the use of IMRT on the basis of chemotherapy is more effective than the conventional two-dimensional radiotherapy, which can reduce the proportion of grade 4 (severe) acute oral mucosa reaction. It may be related to the protective effect of IMRT on immune function in the patients.

miR-663b promotes tumor cell proliferation, migration and invasion in nasopharyngeal carcinoma through targeting TUSC2.

The authors' previous study revealed that the serum levels of microRNA (miR)-663b are significantly increased in patients with nasopharyngeal carcinoma (NPC), and are associated with NPC progression and poor prognosis. However, the molecular mechanism of underlying NPC growth and metastasis remains unclear. In the present study, quantitative polymerase chain reaction and western blot analyses were performed to examine changes to mRNA and protein expression, respectively. MTT, wound healing and Transwell assays were used to examine cell proliferation, migration and invasion, respectively. Luciferase reporter gene assays were performed to identify target genes of miR-663b. It was demonstrated that miR-663b was significantly upregulated in NPC tissue compared with non-tumor nasopharyngeal epithelial tissue samples. Furthermore, miR-663b expression gradually increased with advancing stages of NPC, with the highest expression being observed in the latest stage IV. The increased expression of miR-663b was associated with advanced clinical stage and lymph node metastasis. In addition, miR-663b expression was increased in NPC cell lines compared with normal nasopharyngeal epithelial NP69 cells. Knockdown of miR-663b resulted in a significant reduction in the proliferation, migration and invasion of NPC CNE1 cells. Tumor suppressor candidate 2 (TUSC2) was identified as a novel target gene of miR-663b. It was further demonstrated that TUSC2 was significantly downregulated in NPC tissue samples and cell lines. miR-663b negatively regulated the expression of TUSC2 at the post-transcriptional level in CNE1 cells. Additionally, inhibition of TUSC2 expression attenuated the suppressive effects of miR-663b downregulation on the proliferation, migration and invasion of CNE1 cells. To the best of our knowledge, this is the first study to demonstrate that miR-663b, which is upregulated in NPC, promotes the proliferation, migration and invasion of NPC cells, partially through the inhibition of TUSC2 expression. Therefore, it is suggested that miR-663b is a promising therapeutic target for the treatment of patients with NPC.

miR-663 promotes NPC cell proliferation by directly targeting CDKN2A.

MicroRNAs (miRs) act as important regulators during the development and progression of human cancer; however, the regulatory mechanism of miR-663 in nasopharyngeal carcinoma (NPC) remains unclear. The present study demonstrated that serum miR­663 levels were significantly increased in patients with NPC compared with healthy controls. In addition, the serum levels of miR­663 were associated with the grade, lymph node metastasis and clinical stage of NPC. The expression of miR­663 was increased in NPC C666­1 cells, compared with normal nasopharyngeal epithelial NP69 cells. The knockdown of miR­663 markedly decreased the proliferation of C666­1 cells through the induction of cell cycle arrest at the G1 stage. Cyclin­dependent kinase inhibitor 2A (CDKN2A) was hypothesized to be a putative target of miR­663. Further investigation confirmed that miR­663 was able to directly bind to the 3' untranslated region of CDKN2A mRNA, and to negatively regulate CDKN2A protein expression in C666­1 cells. Inhibition of CDKN2A expression attenuated the suppressive effects of miR­663 knockdown on the proliferation and cell cycle progression of C666­1 cells. In addition, it was observed that the mRNA and protein levels of CDKN2A were decreased in C666­1 cells compared with NP69 cells. In conclusion, the results of the present study demonstrated that miR­663 promoted the proliferation and cell cycle progression of NPC cells by directly targeting CDKN2A, suggesting that miR­663 may become a potential therapeutic target for the treatment of NPC.

Increased Serum Level of MicroRNA-663 Is Correlated with Poor Prognosis of Patients with Nasopharyngeal Carcinoma.

MicroRNAs (miRs) play crucial roles in the carcinogenesis and malignant progression of human cancers including nasopharyngeal carcinoma (NPC). In this study, we aimed to investigate the association of serum miR-663 levels with the clinical factors and prognosis of NPC patients. Real-time PCR was performed to examine the amount of miR-663 in serum in NPC patients and healthy controls. Our data showed that the amount of miR-663 in serum was significantly higher in NPC patients than in healthy controls. Moreover, the serum levels of miR-663 were significantly correlated with the grade, lymph node metastasis, and clinical stage of NPC. Furthermore, higher serum miR-663 levels were closely associated with worse 5-year overall survival (OS) and relapse-free survival (RFS) of patients with NPC, and the serum level of miR-663 was found to be an independent predicator for the prognosis of NPC. In addition, after receiving chemoradiotherapy, the serum levels of miR-663 were significantly reduced in NPC patients. In summary, miR-663 was upregulated in the serum of NPC patients, which was downregulated after chemoradiotherapy, and its increased levels were closely associated with malignant progression and poor prognosis in NPC patients. Therefore, the amount of miR-663 in serum may become a potential predicator for the clinical outcome of NPC patients.

[Foraging habitat selection of Siberian Crane (Grus leucogeranus) during autumn migration period in the Momoge Nature Reserve].

In autumn of 2008 and 2009, we studied the foraging habitat selection of Siberian Crane (Grus leucogeranus) in the Momoge Nature Reserve of Jilin province. Using the resource selection index, resource selection functions, and the chi-squared test, we found that the Siberian Crane exhibited selectivity in their preferred foraging environments in relation to the distance to human disturbances, vegetation density, coverage and height, foraging vegetation density and water level. Interestingly, this selectivity in regards to large scale disturbances was lower than other factors. The characteristics of favorite foraging habits of Siberian Cranes include a variety of factors: a distance >5 000 m from a national highway, >1 500 m from a non-gravel road, >1 000 m from the nearest road, >1 000 m from a residential area, >1 000 m from farmland; plant density between 20 and 50 grass/m(2); plant coverage lower than 10%; plant height lower than 20 cm; Scirpus planiclmis density between 1 and 50 grass/m(2); Scirpus triqueter density between 1 and 10 grass/m(2); and the water level between 40 and 60 cm. The resource selection functions of Siberian Crane foraging habitat in autumn can be described thusly: Logistic (P) = 0.663 + 0.565×distance to national highway + 0.042×distance to non-gravel road + 0.519×distance to the nearest road + 0.353×distance to residential area + 0.169×distance to farmland - 0.455×vegetation density - 0.618×vegetation coverage - 0.548×vegetation height - 0.158×Scirpus planiclmis density - 0.404×Scirpus triqueter density + 0.920×water level,T (x) =e(Logistic(p)) / [1 + e(Logistic(p))], with an overall prediction accuracy of 82.9%.